Novo Nordisk A/S (NVO)
38.05
-0.53
(-1.37%)
USD |
NYSE |
Oct 13, 16:00
38.06
+0.01
(+0.03%)
After-Hours: 17:30
Novo Nordisk Price : 38.05 for Oct. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 38.85 | 38.85 | 38.26 | 38.58 | 8.722M |
| Oct 09, 2026 | 38.11 | 38.68 | 38.06 | 38.64 | 9.645M |
| Oct 08, 2026 | 37.80 | 38.23 | 37.50 | 38.18 | 11.82M |
| Oct 07, 2026 | 37.57 | 38.47 | 37.51 | 38.26 | 13.67M |
| Oct 06, 2026 | 37.35 | 37.53 | 36.84 | 37.53 | 13.70M |
| Oct 05, 2026 | 36.94 | 37.61 | 36.86 | 37.54 | 18.70M |
| Oct 02, 2026 | 37.64 | 37.65 | 37.17 | 37.32 | 10.26M |
| Oct 01, 2026 | 37.80 | 37.97 | 37.36 | 37.40 | 12.66M |
| Sep 30, 2026 | 38.05 | 38.77 | 37.88 | 37.91 | 21.56M |
| Sep 29, 2026 | 38.21 | 38.38 | 38.05 | 38.31 | 9.404M |
| Sep 28, 2026 | 38.40 | 38.90 | 38.23 | 38.71 | 11.43M |
| Sep 25, 2026 | 38.81 | 38.83 | 38.41 | 38.80 | 10.06M |
| Sep 24, 2026 | 37.95 | 38.72 | 37.92 | 38.62 | 20.06M |
| Sep 23, 2026 | 38.90 | 39.14 | 38.16 | 38.17 | 18.44M |
| Sep 22, 2026 | 39.50 | 39.89 | 39.10 | 39.40 | 24.46M |
| Sep 21, 2026 | 41.05 | 41.17 | 39.54 | 39.80 | 49.34M |
| Sep 18, 2026 | 43.50 | 43.54 | 42.78 | 43.24 | 10.37M |
| Sep 17, 2026 | 41.98 | 43.44 | 41.96 | 43.19 | 12.95M |
| Sep 16, 2026 | 42.47 | 42.72 | 41.47 | 41.71 | 11.67M |
| Sep 15, 2026 | 42.72 | 43.00 | 42.40 | 42.53 | 8.862M |
| Sep 14, 2026 | 43.66 | 43.71 | 43.07 | 43.45 | 6.565M |
| Sep 11, 2026 | 43.20 | 43.50 | 42.72 | 43.07 | 11.03M |
| Sep 10, 2026 | 44.60 | 44.82 | 44.01 | 44.01 | 6.581M |
| Sep 09, 2026 | 45.00 | 45.40 | 44.52 | 44.56 | 8.834M |
| Sep 08, 2026 | 45.58 | 45.91 | 45.14 | 45.16 | 10.35M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 155.84 |
| GSK Plc | 46.26 |
| Johnson & Johnson | 248.60 |
| Eli Lilly & Co. | 1166.92 |
| Merck & Co., Inc. | 142.01 |
Price Related Metrics
| PE Ratio | 9.299 |
| PS Ratio | 3.288 |
| PEG Ratio | 0.7380 |
| Price to Book Value | 4.970 |
| Price to Free Cash Flow | 22.50 |
| Earnings Yield | 10.75% |
| Market Cap | 127.31B |
| PEGY Ratio | 0.5389 |
| Operating PE Ratio | 7.245 |
| Normalized PE Ratio | 8.939 |